drugset / Trial / NCT01771822

Ibuprofen 5% Topical Gel CIPT

NCT01771822

Phase 1 Completed 50 enrolled Pfizer
RandomizedSingle-groupOpen-labelBasic science

Summary

This study will determine the potential of Ibuprofen 5% Topical Gel and its vehicle gel to cause irritation after repeated topical application to the healthy skin of human subjects under controlled conditions.

Timeline

Start
2013-01
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 0.2 ml Topical
Subject Ibuprofen Small molecule 5 % Topical
Comparator Sodium Lauryl Sulfate Small molecule 0.2 % Topical
Comparator Sodium Lauryl Sulfate Small molecule 0.2 ml Topical

Indications

No indication recorded.